Ipamorelin Product Brief

Ready-to-Sell Research Product Sheet

1. Compound Overview

Ipamorelin is a synthetic pentapeptide belonging to the growth hormone releasing peptide (GHRP) family.
It functions as a selective ghrelin receptor (GHS-R1a) agonist, which stimulates the release of endogenous growth hormone from the pituitary gland.

Ipamorelin is commonly studied in research involving growth hormone signaling, recovery pathways, metabolic regulation, and endocrine system function.

2. Mechanism of Interest

Ipamorelin is studied for several biological mechanisms:

• Activation of the ghrelin receptor (GHS-R1a)
  • Stimulation of endogenous growth hormone release
  • Potential increase in circulating IGF-1 signaling pathways
  • Influence on metabolic and recovery-related signaling pathways
  • Interaction with endocrine regulatory systems

3. Research Areas Being Explored

• Growth hormone secretion research
  • Body composition studies
  • Recovery and regenerative pathway research
  • Metabolic signaling studies
  • Endocrine system regulation research

4. Suggested Research Vial Sizes

• 5 mg lyophilized vial
  • 10 mg lyophilized vial
  • 20 mg research vial
  • 50 mg laboratory vial

5. Example Reconstitution Chart

Example mixing protocols commonly used in research contexts:

5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL concentration

10 mg vial + 2 mL bacteriostatic water = 5 mg/mL concentration

20 mg vial + 4 mL bacteriostatic water = 5 mg/mL concentration

These concentrations allow accurate measurement using insulin syringes for laboratory research settings.

6. Label Information for Vials

• Compound name: Ipamorelin
  • Total amount per vial (mg)
  • Lot / batch number
  • Manufacturing date
  • Storage instructions (2–8°C recommended)
  • Research use only disclaimer

7. Market Positioning

Ipamorelin is commonly positioned in the growth hormone research peptide category.

It is frequently associated with research exploring:

• Growth hormone secretion models
  • Recovery and regenerative studies
  • Metabolic regulation pathways
  • Endocrine signaling research

8. Example Research Stack Categories

• Ipamorelin + CJC-1295 (No DAC)
  • Ipamorelin + CJC-1295 (with DAC)
  • Ipamorelin + BPC-157
  • Ipamorelin + TB-500

9. Safety and Regulatory Notes

Ipamorelin is not approved by the FDA for medical treatment and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.